genentech ltgeneo in imaging drug venture seattle oct privatelyheld neorx corp said it has entered into an exclusive agreement with genentech inc for the development of an injectable diagnostic to image blood clots it said it genentech will be responsible for marketing and neorx will receive royalties based on sales the product will use a proprietary neorx method of attaching the radioisotope technetiumm to genentechs blood clot dissolving drug tissue plasminogen activator or activase reuter